Conduent Q2 adjusted EBITDA drops 30.4% Y/Y to USD 16 million; revenue falls 11.9% Y/Y to USD 531 million
Reuters2026/08/10 13:23- Conduent posted Q2 2026 revenue of USD 531 million, down 11.9% year over year.
- Non-GAAP adjusted EBITDA fell 30.4% to USD 16 million; margin narrowed 0.8 percentage points to 3%.
- Non-GAAP net loss from continuing operations widened to USD 69 million; adjusted net loss was USD 26 million.
- New business signings annual contract value slipped to USD 99 million from USD 111 million a year earlier.
- Kept FY 2026 outlook for revenue at USD 2.15 billion-USD 2.25 billion; adjusted EBITDA from continuing operations at USD 140 million-USD 170 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Spot bitcoin ETFs pull in $987 million last week as institutional demand recovers
Silver Price Forecast: XAG/USD dips below $66.00 and hints at a bearish “H&S”
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well
Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.
